Cargando…
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors
The sinonasal cavities harbor a wide variety of rare cancer types. Histopathological classification can be challenging, especially for poorly differentiated tumors. Despite advances in surgery and radio-chemotherapy, the 5-year survival rate is still very low. Thus, there is an unmet clinical need f...
Autores principales: | Villanueva-Fernández, Eva, Hermsen, Mario A., Suárez-Fernández, Laura, Vivanco, Blanca, Franchi, Alessandro, García-Marín, Rocío, Cabal, Virginia N., Codina-Martínez, Helena, Lorenzo-Guerra, Sara Lucila, Llorente, José L., López, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496628/ https://www.ncbi.nlm.nih.gov/pubmed/36140305 http://dx.doi.org/10.3390/biomedicines10092205 |
Ejemplares similares
-
Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma
por: Codina-Martínez, Helena, et al.
Publicado: (2023) -
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas
por: López, Luis, et al.
Publicado: (2023) -
CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020) -
Genetic profiling of poorly differentiated sinonasal tumours
por: López-Hernández, Alejandro, et al.
Publicado: (2018) -
Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma
por: Riobello, Cristina, et al.
Publicado: (2021)